Key facts
- DermaSense’s last known valuation is $1.4M (Apr 2025).
- It has raised $80K; the latest was Seed Round ($80K) in Apr 2025.
- Notable investors include Oxford Technology Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for DermaSense
- ·The full record, as it builds
Funding rounds
No funding rounds for DermaSense are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DermaSense
Developer of a sensor technology designed to address challenges in wearable diagnostics. The company's platform offers sensor design and development, enabling healthcare professionals and individuals to access real-time health monitoring for improved medical insights.
- Sector
- Healthcare
- HQ
- Neston, United Kingdom
- Founded
- 2022
- Ownership
- Privately Held (backing)
DermaSense doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DermaSense shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DermaSense in its N-PORT filings yet. We sweep new filings monthly.